| Autor: |
Ghany, Hosny Saied A., Samra, Manal Fayez Abu, El-Saieed, May, Gerges, Amany Saber, Hasan, Ebtesam Ismaiel, Rahman, Ahmed Abdel, Toni, Nisreen D.M. |
| Zdroj: |
Egyptian Journal of Radiology & Nuclear Medicine; Dec2018, Vol. 49 Issue 4, p1030-1035, 6p |
| Abstrakt: |
Abstract Aim To evaluate role of DW-MRI and ADC value in monitoring therapy of head and neck squamous cell carcinoma (HNSCC). Patients & methods Fourty patients with head and neck squamous cell carcinoma, age ranged from 40 to 68 years, 30 patients were male while 10 were female. Pre-treatment examinations included contrast-enhanced CT, endoscopic biopsy & MRI study. Pre-treatment 1st DW-MRI imaging within 10 days before treatment (ADC1), 2nd imaging 3 weeks after start of treatment (ADC2) and 3rd after 6–8 weeks from end of treatment. Results Significant changes between mean ADC value of 40 primary lesions & 22 metastatic LNs, noted at ADC1 and ADC2, indicating high ability of DW-MRI to detect early changes occur after beginning of treatment. Relationship between pretreatment ADC value and prediction of early treatment response revealed 76.9% sensitivity, 71.4% specificity, 83.3% PPV and 62.5% NPV. ROC curve for fractional ADC value change (ADC2 - ADC1) from 40 lesions primary tumors provided best discriminatory accuracy (AUC = 0.85 ± 0.09) in distinguishing between responders and non-responders with 92.3% sensitivity, 85.7% specificity, 92.9% PPV and 85.7% NPV. Conclusion Intra treatment ADC value can be used as a marker for prediction and monitoring therapy response for HNSCC. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
